Johnson & Johnson
JNJ · NYSE
9/28/2025 | 6/29/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $23,993 | $23,743 | $21,893 | $22,520 |
| % Growth | 1.1% | 8.5% | -2.8% | – |
| Cost of Goods Sold | $7,303 | $7,628 | $7,357 | $7,128 |
| Gross Profit | $16,690 | $16,115 | $14,536 | $15,392 |
| % Margin | 69.6% | 67.9% | 66.4% | 68.3% |
| R&D Expenses | $3,672 | $3,516 | $3,225 | $5,298 |
| G&A Expenses | $5,922 | $5,789 | $5,012 | $6,253 |
| SG&A Expenses | $5,922 | $5,789 | $5,012 | $6,253 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $9,594 | $9,305 | $8,237 | $11,551 |
| Operating Income | $7,096 | $6,810 | $6,299 | $3,841 |
| % Margin | 29.6% | 28.7% | 28.8% | 17.1% |
| Other Income/Exp. Net | $397 | -$319 | $7,332 | $46 |
| Pre-Tax Income | $7,493 | $6,491 | $13,631 | $3,887 |
| Tax Expense | $2,341 | $954 | $2,632 | $456 |
| Net Income | $5,152 | $5,537 | $10,999 | $3,431 |
| % Margin | 21.5% | 23.3% | 50.2% | 15.2% |
| EPS | 2.12 | 2.29 | 4.57 | 1.43 |
| % Growth | -7.4% | -49.9% | 219.6% | – |
| EPS Diluted | 2.12 | 2.29 | 4.54 | 1.41 |
| Weighted Avg Shares Out | 2,429 | 2,419 | 2,406 | 2,407 |
| Weighted Avg Shares Out Dil | 2,429 | 2,419 | 2,424 | 2,427 |
| Supplemental Information | – | – | – | – |
| Interest Income | $227 | $260 | $332 | $281 |
| Interest Expense | $18 | $308 | $204 | $137 |
| Depreciation & Amortization | $1,777 | $1,943 | $1,772 | $1,896 |
| EBITDA | $9,288 | $8,742 | $15,607 | $5,920 |
| % Margin | 38.7% | 36.8% | 71.3% | 26.3% |